TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ALKS

Alkermes Plc

Healthcare · Drug Manufacturers - Specialty & Generic

44.20$ +1.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ALKS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-462.3% +417.4% -27.4% +14.9% +22.8% -79.3% +1,807.2% +9.4% +18.6%
-12.7% +10.1% +4.5% +5.2% -22.4% +1.8% -3.9% -1.0% -3.8% -61.9% -4.8%
+63.4% -3.0% -11.1% +25.5% -4.2% -10.7% -2.8% +7.6% +7.1% -4.2% +2.2%
+303.6% +7.6% +73.2% -14.6% -20.0% -2.0% -8.3%
+654.9% -133.2% -79.9% -294.6% -388.5%
+57.1% -17.4% +17.5% +35.3% +31.0% -53.6% -31.3% +31.8% +25.6% -30.3% +20.7%
-83.5% -114.4% +20.9% +539.0% -91.9% +476.6% -2.5% -308.6%
-93.0% +1,201.8% -83.7%
+101.7% -48.0% +22.0% +19.4% -52.5% -17.3% +115.2% +9.9% +56.4% +603.4% -84.5%
+0.0% +925.8% -95.7% -4.2% -1.1% +0.0% -114.8% +0.0% +9,626.4% -100.0%
-86.8% -242.3% -139.7% -132.1% -105.4% +18,306.2% +70.6%
-176.0% -6.7% +1,434.5% -183.5% -6.7% -169.8% -200.8%
-163.2% +79.0% -123.7% +14.8% +18.4%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?